Monoclonal Antibody Treatment at home at no cost available in Tampa Bay area

Those who would like to receive COVID-19 Monoclonal Antibody Treatment can now receive it in the comfort of their home. DeliveRxd Pharmacy will provide the treatment to those who may need it and live in the following counties: Citrus, Hardee, Hernando, Hillsborough, Manatee, Pasco, Pinellas, Polk, Sarasota, and Sumter.

Those who would like this option do not have to be homebound or bedridden. Additionally, DeliveRxd Pharmacy continues to offer the COVID-19 vaccine to those in Hillsborough and Pinellas. There is no out-of-pocket cost to those who choose the services.

“We are excited to add this as an option for those in the region,” said William Parker, president and founder of DeliveRxd Pharmacy. “We aim to improve the health and wellness of every patient that we serve. We aspire to deliver the highest quality and most comprehensive pharmacy healthcare services. Our commitment to integrity and improving the health and wellness of our patients will forever guide us.”

“Once again DeliveRxd Pharmacy has stepped up to offer our region a service that is not offered in most other places around the nation and world, said Dr. Douglas Holt, director of the Florida Department of Health in Hillsborough County. “In addition to being a convenient option, this also helps reduce access issues.”

To schedule at home COVID-19 monoclonal antibody treatment or vaccination, call 813-932-6266.

Eligibility – screening will be carried out by DeliveRxd Pharmacy. 

Post-exposure prophylaxis for adults and pediatric individuals (12 years of age and older weighing at least 40 kg) who are:

  • at high risk for progression to severe COVID-19, including hospitalization or death, and
  • not fully vaccinated or who are not expected to mount an adequate immune response to complete SARS-CoV-2 vaccination (for example, people with immunocompromising conditions, including those taking immunosuppressive medications), and
    • have been exposed to an individual infected with SARS-CoV-2 consistent with close contact criteria per Centers for Disease Control and Prevention (CDC), or
    • who are at high risk of exposure to an individual infected with SARS-CoV-2 because of occurrence of SARS-CoV-2 infection in other individuals in the same institutional setting (for example, nursing homes or prisons)

Leave a Reply

Your email address will not be published. Required fields are marked *